Skip to main content
SpringerLink
Log in

CD14 and apoptosis

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

In addition to its role as a mediator of innate pro-inflammatory responses following bacterial lipopolysaccharide (LPS) binding, the 55kDa glycosyl-phosphatidylinositol-linked macrophage plasma membrane glycoprotein CD14 is now also known to play a role in phagocytic clearance of apoptotic cells. Although apoptotic cell-associated ligand(s) for CD14 await definition, initial findings suggest that ligand binding occurs close to, or at the same site as, LPS binding. Significantly, in contrast to LPS clearance and in keeping with the non-phlogistic nature of apoptosis, CD14-dependent engulfment of apoptotic cells fails to elicit pro-inflammatory cytokine release from macrophages. Therefore CD14 may be regarded as an innate immune receptor both for microbial products—after binding which activates inflammatory responses—and for self components, which either fail to induce, or alternatively actively suppress, inflammatory responses. Here we review current knowledge of the structure and functions of CD14, its ligands, its possible modes of signal transduction and its place in the panoply of macrophage molecules implicated in apoptotic-cell clearance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wright SD, Ramos RA, Tobias PS, Ulevitch, RJ Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.

    Google Scholar 

  2. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Ann Rev Immunol 1995; 13: 437-457.

    Google Scholar 

  3. Beekhuizen H, Blokland I, Corselvantilburg AJ, Koning F, Vanfurth R. CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol 1991; 147: 3761-3767.

    Google Scholar 

  4. Lue KH, Lauener RP, Winchester RJ, Geha RS, Vercelli D. Engagement of CD14 on human monocytes terminates T-cell proliferation by delivering a negative signal to T cells. J Immunol 1991; 147: 1134-1138.

    Google Scholar 

  5. Jabara HH, Vercelli D. Engagement of CD14 on monocytes inhibits the synthesis of human Igs, including IgE. J Immunol 1994; 153: 972-978.

    Google Scholar 

  6. Haziot A, et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4: 407-414.

    Google Scholar 

  7. Devitt A, et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998; 392: 505-509.

    Google Scholar 

  8. Heidenreich S, et al. Regulation of human monocyte apoptosis by the CD14 molecule. J Immunol 1997; 159: 3178-3188.

    Google Scholar 

  9. Frey EA, Finlay BB. Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14 dependent pathway. Microbial Pathogenesis 1998; 24: 101-109.

    Google Scholar 

  10. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 1981; 68: 932-941.

    Google Scholar 

  11. Todd RF, Nadler LM, Schlossman SF. Antigens on human-monocytes identified by monoclonal antibodies. J Immunol 1981; 126: 1435-1442.

    Google Scholar 

  12. Goyert SM, et al. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988; 239: 497-500.

    Google Scholar 

  13. Simmons DL, Tan S, Tenen DG, Nicholson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 1989; 73: 284-289.

    Google Scholar 

  14. Gadd S. In: Knapp W, ed. Leukocyte Typing IV White Cell Differentiation Antigens. Oxford, UK: Oxford University Press, 1989: 787-789.

    Google Scholar 

  15. Ziegler-Heitbrock HWL, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993; 14: 121-125.

    Google Scholar 

  16. Guilbert L, Robertson SA, Wegmann TG. The trophoblast as an integral component of a macrophage cytokine network. Immunol Cell Biology 1993; 71: 49-57.

    Google Scholar 

  17. Hailman E, et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exper Med 1994; 179: 269-277.

    Google Scholar 

  18. Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high-density lipoprotein. J Exper Med 1995; 181: 1743-1754.

    Google Scholar 

  19. Wurfel MM, Wright SD. Lipopolysaccharide binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers—preferential interaction with particular classes of lipid. J Immunol 1997; 158: 3925-3934.

    Google Scholar 

  20. Yu B, Hailman E, Wright SD. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 1997; 99: 315-324.

    Google Scholar 

  21. Petty HR, Todd RF. Integrins as promiscuous signal transduction devices. Immunol Today 1996; 17: 209-212.

    Google Scholar 

  22. Joseph CK, et al. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J Biolog Chem 1994; 269: 17606-17610.

    Google Scholar 

  23. Thieblemont N, Thieringer R, Wright SD. Innate immune recognition of bacterial lipopolysaccharide: dependence on interactions with membrane lipids and endocytic movement. Immunity 1998; 8: 771-777.

    Google Scholar 

  24. Lee JD, et al. Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Nat Acad Sci USA 1993; 90: 9930-9934.

    Google Scholar 

  25. Yang R-B, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998; 395: 284-288.

    Google Scholar 

  26. Vita N, et al. Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide. J Immunol 1997; 158: 3457-3462.

    Google Scholar 

  27. Juan TSC, Hailman E, Kelley MJ, Wright SD, Lichenstein HS. Identification of a domain in soluble CD14 essential for lipopolysaccharide (LPS) signaling but not LPS binding. J Biolog Chem 1995; 270: 17237-17242.

    Google Scholar 

  28. Stelter F, et al. Mutation of amino acids 39–44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Euro J Biochem 1997; 243: 100-109.

    Google Scholar 

  29. Juan TSC, et al. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J Biolog Chem 1995; 270: 5219-5224.

    Google Scholar 

  30. McGinley MD, et al. CD14-physical properties and identification of an exposed site that is protected by lipopolysaccharide. J Biolog Chem 1995; 270: 5213-5218.

    Google Scholar 

  31. Pugin J, et al. CD14 is a pattern recognition receptor. Immunity 1994; 1: 509-516.

    Google Scholar 

  32. Medzhitov R, Janeway CA. Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997; 91: 295-298.

    Google Scholar 

  33. Kitchens RL, Ulevitch RJ, Munford RS. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J Exper Med 1992; 176: 485-494.

    Google Scholar 

  34. Kitchens RL, Munford RS. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J Biolog Chem 1995; 270: 9904-9910.

    Google Scholar 

  35. Savedra R, Delude RL, Ingalls RR, Fenton MJ, Golenbock DT. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J Immunol 1996; 157: 2549-2554.

    Google Scholar 

  36. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-305.

    Google Scholar 

  37. Savill J. Phagocyte recognition of apoptotic cells. Biochem Soc Trans 1996; 24: 1065-1069.

    Google Scholar 

  38. Ren Y, Savill J. Apoptosis: The importance of being eaten. Cell Death Diff 1998; 5: 563-568.

    Google Scholar 

  39. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Diff 1998; 5: 551-562.

    Google Scholar 

  40. Savill J. Apoptosis—Phagocytic docking without shocking. Nature 1998; 392: 442-443.

    Google Scholar 

  41. Savill J, Dransfield I, Hogg N, Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990; 343: 170-173.

    Google Scholar 

  42. Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992; 90: 1513-1522.

    Google Scholar 

  43. Luciani M-F, Chimini G. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J 1996; 15: 226-235.

    Google Scholar 

  44. Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S. Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc Nat Acad Sci USA 1996; 93: 12456-12460.

    Google Scholar 

  45. Ellis RE, Jacobson DM, Horvitz HR. Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis elegans. Genetics 1991; 129: 79-94.

    Google Scholar 

  46. Wu YC, Horvitz HR. The C. elegans cell corpse engulfment gene ced-7 encodes a protein similar to ABC transporters. Cell 1998; 93: 951-960.

    Google Scholar 

  47. Wu YC, Horvitz HR. C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180. Nature 1998; 392: 501-504.

    Google Scholar 

  48. Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunol 1985; 56: 351-358.

    Google Scholar 

  49. Dini L, Autuori F, Lentini A, Oliverio S, Piacentini M. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett 1992; 296: 174-178.

    Google Scholar 

  50. Hall SE, Savill JS, Henson PM, Haslett C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J Immunol 1994; 153: 3218-3227.

    Google Scholar 

  51. Fadok VA, et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-2216.

    Google Scholar 

  52. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exper Med 1995; 182: 1597-1601.

    Google Scholar 

  53. Koopman G, et al. Annexin-V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-1420.

    Google Scholar 

  54. Stern M, Savill J, Haslett C. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis—mediation by alpha(v)beta(3)/cd36/ thrombospondin recognition mechanism and lack of phlogistic response. Amer J Pathol 1996; 149: 911-921.

    Google Scholar 

  55. Voll RE, et al. Immunosuppressive effects of apoptotic cells. Nature 1997; 390: 350-351.

    Google Scholar 

  56. Fadok VA, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.

    Google Scholar 

  57. Flora PK, Gregory CD. Recognition of apoptotic cells by human macrophages—inhibition by a monocyte/macrophage-specific monoclonal antibody. Euro J Immunol 1994; 24: 2625-2632.

    Google Scholar 

  58. Pradhan D, Krahling S, Williamson P, Schlegel RA. Multiple systems for recognition of apoptotic lymphocytes by macrophages. Mol Biol Cell 1997; 8: 767-778.

    Google Scholar 

  59. Fadok VA, et al. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149: 4029-4035.

    Google Scholar 

  60. Flora PK, Gregory CD. In: Schlossman SF, ed. Leucocyte Typing V. White Cell Differentiation Antigens. Oxford, UK: Oxford University Press, 1995: 1675-1677.

    Google Scholar 

  61. Flora PK, Devitt A, Johnson GD, Milner AE, Gregory CD. Bcl-2 delays macrophage engulfment of human B cells induced to undergo apoptosis. Euro J Immunol 1996; 26: 2243-2247.

    Google Scholar 

  62. Devitt A, Pierce S, Moffatt OD, Gregory CD. Role of human macrophage CD14 in clearance of apoptotic cells: lack of involvement of phosphatidylserine. 1998 (submitted).

  63. Moffatt OD, Devitt A, Bell ED, Simmons DL, Gregory CD. Macrophage recognition of ICAM-3 on apoptotic leukocytes. J Immunol 1999 (in press).

  64. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs. Nature 1998; 392: 86-89.

    Google Scholar 

  65. Austyn JM. Dendritic cells. Curr Opin Hematol 1998; 5: 3-15.

    Google Scholar 

  66. Wooten RM, et al. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol 1998; 160: 5485-5492.

    Google Scholar 

  67. Weidemann B, et al. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun 1994; 62: 4709-4715.

    Google Scholar 

  68. Gupta D, Jin YP, Dziarski R. Peptidoglycan induces transcription and secretion of TNF-alpha and activation of lyn, extracellular signal-regulated kinase, and rsk signal-transduction proteins in mouse macrophages. J Immunol 1995; 155: 2620-2630.

    Google Scholar 

  69. Gupta D, Kirkland TN, Viriyakosol S, Dziarski R. CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biolog Chem 1996; 271: 23310-23316.

    Google Scholar 

  70. Weidemann B, et al. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun 1997; 65: 858-864.

    Google Scholar 

  71. Dziarski R, Tapping RI, Tobias PS. Binding of bacterial peptidoglycan to CD14. J Biolog Chem 1998; 273: 8680-8690.

    Google Scholar 

  72. Espevik T, et al. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Euro J Immunol 1993; 23: 255-261.

    Google Scholar 

  73. Zhang YH, Doerfler M, Lee TC, Guillemin B, Rom WN. Mechanisms of stimulation of interleukin-1-beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J Clin Invest 1993; 91: 2076-2083.

    Google Scholar 

  74. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996; 64: 1906-1912.

    Google Scholar 

  75. Kusunoki T, Hailman E, Juan TSC, Lichenstein HS, Wright SD. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exper Med 1995; 182: 1673-1682.

    Google Scholar 

  76. Hmama Z, Mey A, Normier G, Binz H, Revillard JP. CD14 and CD11b mediate serum-independent binding to human monocytes of an acylpolygalactoside isolated from Klebsiella pneumoniae. Infect Immun 1994; 62: 1520-1527.

    Google Scholar 

  77. Soell M, et al. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan-binding protein inhibits TNF-alpha release. J Immunol 1995; 154: 851-860.

    Google Scholar 

  78. Cavaillon JM, et al. CD14/LPS receptor exhibits lectin-like properties. J Endotoxin Res 1996; 3: 471-480.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Cell Signalling and School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, UK

    C. D. Gregory & A. Devitt

Authors
  1. C. D. Gregory
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Devitt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gregory, C.D., Devitt, A. CD14 and apoptosis. Apoptosis 4, 11–20 (1999). https://doi.org/10.1023/A:1009673914340

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009673914340

Search

Navigation